Get Critical Health Info

No one should face hereditary cancer alone.

Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.

Hereditary Cancer Info > Cancer Treatment > PARP Inhibitor Therapy

| More

BRCA & HBOC
Toggle Menu

PARP Inhibitor Therapy

Learn how genetic test results may affect medical decisions about cancer treatment.”

Iniparib

Iniparib is a drug that was studied as a PARP inhibitor for treating triple-negative breast cancer. Iniparib was shown to be ineffective in treating triple-negative breast cancer. Researchers determined that this drug is not a true PARP inhibitor. It includes a chemical group that is not present in other PARP inhibitors that makes it difficult for iniparib to bind PARP. 

Updated 12/27/16

FORCE:Facing Our Risk of Cancer Empowered